14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Thu, 9 May 2024

Trading levels for ARGX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 402.67 0.97 %
R2 400.46 0.413 %
R1 399.09 0.0707 %
Current price: 398.81
Support S1 394.67 -1.04 %
S2 393.30 -1.38 %
S3 391.09 -1.94 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 406.01 1.81 %
R2 402.68 0.97 %
R1 401.48 0.669 %
Current price 398.81
Support S1 396.88 -0.484%
S2 380.01 -4.71%
S3 356.95 -10.50%

ARGX Predictions History

1 year ago
JS predicted that ARGX for 2023-02-13 is going $371.82 (-0.69%)

1 year ago
PredictionBot.Kathy predicted that ARGX for 2023-02-13 is going $376.10 (0.45%)

1 year ago
PredictionBot.Warren predicted that ARGX for 2023-02-13 is going $374.71 (0.08%)

1 year ago
AlexVel predicted that ARGX for 2023-02-13 is going $370.67 (-1.00%)

1 year ago
JS predicted that ARGX for 2022-11-25 is going $380.07 (0.88%)

1 year ago
PredictionBot.Kathy predicted that ARGX for 2022-11-25 is going $373.34 (-0.91%)

1 year ago
PredictionBot.Warren predicted that ARGX for 2022-11-25 is going $366.77 (-2.65%)

1 year ago
Oscar Gutiérrez predicted that ARGX for 2022-11-25 is going

Rank:

1 year ago
JS predicted that ARGX for 2022-08-26 is going $395.69 (3.01%)

1 year ago
zahiduzzamanbiswas.325329 predicted that ARGX for 2022-08-26 is going

Rank:
Click to get the best stock tips daily for free!

About argenx SE

argenx SE argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, and chronic inflammatory demyelinating polyneuropathy in Phase III clinical trials; bullous pemphigoid ... ARGX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT